Chien, K. S., Ramdial, J. L., Qiao, W., Romero, L., Montalban-Bravo, G., Short, N. J., Issa, G. C., Ravandi-Kashani, F., Daver, N. G., Kadia, T. M., Kantarjian, H. M., Garcia-Manero, G., DiNardo, C. D. (2025). Phase II study evaluating olutasidenib in patients with
            <i>IDH1</i>
            -mutated clonal cytopenia of undetermined significance or lower-risk myelodysplastic syndromes/chronic myelomonocytic leukemia.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps6585